On November 9, Aero's trading pools on the newly launched Elysium network recorded $147,285 in trading volume. This figure reflects activity in the pools but not direct trading of the AERO token itself. Stakers of Aero earned $106 in fee revenue from pools that distribute AERO rewards, which requires new funds to enter those pools. Elysium, built by Kinetiq for the Hyperliquid ecosystem, combines the Aerodrome and Velodrome decentralized exchanges, marking a significant step in expanding decentralized trading options.
Aero's Elysium Pools reported $147,285 in first-day trading volume, providing context for decentralized trading activity. For readers following cryptocurrency markets, here is Pluang's snapshot as of Nov 11, 2026 15:01 WIB: out of 50 major cryptocurrencies, only 8 rose while 41 fell. Among notable movers, GRT fell 4.08% to Rp317 with 100% sell orders, XRP dropped 3.77% to Rp19,104 with a near-even buy-sell split, and BCH declined 3.77% to Rp4,140,720 with 59% sell orders.
Rakuten Kobo's 2026 annual report highlights a shift in global reading habits towards niche communities and diverse genres like sports romances, dark romance, and cozy mysteries. The report notes the fragmentation of traditional bestseller lists as r...
Anthropic, an AI company, is reserving up to 20% of its initial public offering (IPO) shares specifically for retail investors. This allocation is significantly higher than the typical 5% to 10% usually offered to individual investors in IPOs. By doi...
DataParser by 17a-4 LLC now supports capturing Zoom AI meeting summaries along with transcripts and recordings for regulatory compliance. This solution helps firms retain, supervise, and search AI-generated content, closing gaps in archiving platform...
At the 9th China International Import Expo (CIIE), Shanghai Zhenhua Heavy Industries (ZPMC) signed import procurement contracts worth RMB 2.835 billion with 12 overseas suppliers including Siemens and ABB. This brings ZPMC's cumulative procurement co...
Devia, an AI platform spun out from Visium, has launched to help biopharma companies, CDMOs, and CROs manage GxP quality deviations more efficiently. It automates the entire deviation lifecycle from reporting to root cause analysis and CAPA, reducing...
